HIV Scientific Papers
Metabolic risk factors in responders to tesamorelin, a growth hormone-releasing factor (GRF) analogue, in HIV-infected patients with excess abdominal fat [abstract].
2011
Antiviral Therapy
Falutz J, Assaad H, Marsolais C, et al.
16(suppl 2): A29. Proceedings of the 13th International Workshop on Co-Morbidities and Adverse Drug Reactions in HIV.
Metabolic risk factors in responders to tesamorelin, a growth hormone-releasing factor (GRF) analogue, in HIV-infected patients with excess abdominal fat.
2011
Falutz J, Assaad H, Marsolais C, et al.
"Poster presented at: 13th International Workshop on Adverse Drug Reactions and Co-morbidities in HIV; July 14-16, 2011; Rome, Italy. "
Significant improvement in belly image parameters and health-related quality of life in responders vs. non-responders to tesamorelin, a growth hormone-releasing factor (GRF) analogue, in HIV-infected patients with excess abdominal fat [abstract].
2011
Turner R, Potvin D, Mamputu J-C, et al.
13th European AIDS Conference; October 12-15, 2011; Belgrade, Serbia.
Significant improvement in belly image parameters and health-related quality of life in responders vs. non-responders to tesamorelin, a growth hormone-releasing factor (GRF) analogue, in HIV-infected patients with excess abdominal fat.
2011
Turner R, Potvin D, Mamputu J-C, et al.
Poster PE9.3/2 presented at: 13th European AIDS Conference; October 12-15, 2011; Belgrade, Serbia.
Effects of a growth hormone-releasing hormone analog on endogenous GH pulsatility and insulin sensitivity in healthy men.
2011
J Clin Endocrinol Metab.
Stanley TL, Chen CY, Branch KL, et al.
96(1):150-158. Epub 2010 Oct 13.